1. Home
  2. PTY vs LGND Comparison

PTY vs LGND Comparison

Compare PTY & LGND Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PTY
  • LGND
  • Stock Information
  • Founded
  • PTY 2002
  • LGND 1987
  • Country
  • PTY United States
  • LGND United States
  • Employees
  • PTY N/A
  • LGND 68
  • Industry
  • PTY Investment Managers
  • LGND Biotechnology: Pharmaceutical Preparations
  • Sector
  • PTY Finance
  • LGND Health Care
  • Exchange
  • PTY Nasdaq
  • LGND Nasdaq
  • Market Cap
  • PTY 2.6B
  • LGND 2.2B
  • IPO Year
  • PTY N/A
  • LGND 1992
  • Fundamental
  • Price
  • PTY $13.98
  • LGND $132.72
  • Analyst Decision
  • PTY
  • LGND Strong Buy
  • Analyst Count
  • PTY 0
  • LGND 8
  • Target Price
  • PTY N/A
  • LGND $144.71
  • AVG Volume (30 Days)
  • PTY 550.4K
  • LGND 139.7K
  • Earning Date
  • PTY 01-01-0001
  • LGND 08-05-2025
  • Dividend Yield
  • PTY 9.65%
  • LGND N/A
  • EPS Growth
  • PTY N/A
  • LGND N/A
  • EPS
  • PTY N/A
  • LGND N/A
  • Revenue
  • PTY N/A
  • LGND $181,488,000.00
  • Revenue This Year
  • PTY N/A
  • LGND $18.41
  • Revenue Next Year
  • PTY N/A
  • LGND $18.87
  • P/E Ratio
  • PTY N/A
  • LGND N/A
  • Revenue Growth
  • PTY N/A
  • LGND 53.40
  • 52 Week Low
  • PTY $11.92
  • LGND $81.74
  • 52 Week High
  • PTY $14.88
  • LGND $129.90
  • Technical
  • Relative Strength Index (RSI)
  • PTY 69.25
  • LGND 57.05
  • Support Level
  • PTY $13.73
  • LGND $131.57
  • Resistance Level
  • PTY $13.95
  • LGND $138.02
  • Average True Range (ATR)
  • PTY 0.06
  • LGND 5.25
  • MACD
  • PTY 0.01
  • LGND -0.72
  • Stochastic Oscillator
  • PTY 90.74
  • LGND 50.05

About PTY Pimco Corporate & Income Opportunity Fund

PIMCO Corporate & Income Opportunity Fds operates as a closed-end management investment company. It seeks to maximize total return through a combination of current income and capital appreciation. The fund invests a majority of the total assets in a combination of corporate debt obligations of varying maturities, other corporate income-producing securities, and income-producing securities of non-corporate issuers, such as U.S. Government securities, municipal securities, and mortgage-backed and other asset-backed securities issued on a public or private basis.

About LGND Ligand Pharmaceuticals Incorporated

Ligand Pharmaceuticals Inc is a biopharmaceutical company focused on developing and acquiring technologies that aid in creating medicine. The company has partnerships and license agreements with various pharmaceutical and biotechnology companies. Ligand's business model is based on drug discovery, early-stage drug development, product reformulation, and partnerships. The company's revenue consists of three primary elements: royalties from commercialized products, license and milestone payments, and sale of its trademarked Captisol material.

Share on Social Networks: